Author

N. Martin

Observed name: Martin, N

Institutions: Guy's Hospital, University of Leicester, King's College London, NIHR Leicester Biomedical Research Centre

Observed institutions: Guy's Hospital, University of Leicester, King's College London, NIHR Leicester Biomedical Research Centre

OpenAlex ID: A5043746178

Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and High Baseline Blood Eosinophil Counts

2022 · N. Jain, J. Llanos-Ackert, et al. · Annals of Allergy Asthma & Immunology · 3

Effect of Tezepelumab on Asthma Inflammatory Biomarker Levels Varies by Baseline Biomarker Levels

2022 · J. Corren, J. Spahn, et al. · Annals of Allergy Asthma & Immunology · 3

Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies

2026 · Couillard, S, Meulmeester, FL, et al. · Ghent University Academic Bibliography (Ghent University)

Tezepelumab Efficacy in Patients With Severe Asthma by Blood Eosinophil Count and Perennial Allergy (destination)

2023 · M. Wechsler, T. Carr, et al. · Annals of Allergy Asthma & Immunology

Tezepelumab Reduces All Key Inflammatory Biomarker Levels in Patients With Severe Allergic and Eosinophilic Asthma

2023 · S. Mathur, J. Jacobs, et al. · Annals of Allergy Asthma & Immunology

Efficacy of Tezepelumab in Hispanic or Latino Patients With Severe, Uncontrolled Asthma

2022 · J. Hill, T. Carr, et al. · Annals of Allergy Asthma & Immunology

Efficacy of Biologics in Patients With Severe Allergic Asthma, Overall and by Blood Eosinophil Count

2022 · J. Bernstein, S. Korn, et al. · Annals of Allergy Asthma & Immunology

Asthma Exacerbations Before and After Tezepelumab Treatment: a Pooled Analysis of Pathway and Navigator Studies

2022 · S. Mathur, J. Jacobs, et al. · Annals of Allergy Asthma & Immunology

AAAAI ARIETTA study design poster for DGP

2016 · S. Korn, NA Hanania, et al.

Works count: 11

Citation count: 6

H-index: 2

I10-index: